ATAI Life Sciences N.V. Proxy Statement Filed
Ticker: ATAI · Form: DEFA14A · Filed: Jun 3, 2025 · CIK: 1840904
| Field | Detail |
|---|---|
| Company | Atai Life Sciences N.V. (ATAI) |
| Form Type | DEFA14A |
| Filed Date | Jun 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing
TL;DR
ATAI Life Sciences N.V. filed a proxy statement, shareholders vote soon.
AI Summary
ATAI Life Sciences N.V. filed a DEFA14A proxy statement on June 3, 2025, related to soliciting material under Rule 14a-12. The filing indicates no fee was required for this submission. ATAI Life Sciences N.V. is incorporated in P7 and has its fiscal year end on December 31.
Why It Matters
This filing is a proxy statement, which means shareholders will be asked to vote on certain matters, potentially impacting the company's governance and future direction.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain information about significant financial changes or strategic shifts that would inherently increase risk.
Key Players & Entities
- ATAI Life Sciences N.V. (company) — Registrant
- 0001140361-25-021192 (filing_id) — Accession Number
- 20250603 (date) — Filing Date
- 20250602 (date) — Date as of Change
- 0001840904 (cik) — Central Index Key
- 2834 (sic_code) — Standard Industrial Classification
- P7 (state_of_incorporation) — State of Incorporation
- 1231 (fiscal_year_end) — Fiscal Year End
- 001-40493 (sec_file_number) — SEC File Number
- 49 89 2153 9035 (phone_number) — Business Phone
FAQ
What type of filing is this DEFA14A for ATAI Life Sciences N.V.?
This DEFA14A filing is for soliciting material under Rule 14a-12.
When was this DEFA14A filed?
The DEFA14A was filed on June 3, 2025.
Is there a filing fee associated with this DEFA14A?
No fee is required for this filing.
What is the Central Index Key (CIK) for ATAI Life Sciences N.V.?
The CIK for ATAI Life Sciences N.V. is 0001840904.
What is the fiscal year end for ATAI Life Sciences N.V.?
The fiscal year end for ATAI Life Sciences N.V. is December 31.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 3, 2025 regarding ATAI Life Sciences N.V. (ATAI).